Home - Products - Angiogenesis - c-Met/HGFR - C-Met inhibitor D9

C-Met inhibitor D9

CAS No. 299405-67-7

C-Met inhibitor D9( —— )

Catalog No. M36033 CAS No. 299405-67-7

C-Met inhibitor D9 is a c-Met kinase inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	426	In Stock
10MG	625	In Stock
25MG	938	In Stock
50MG	1283	In Stock
100MG	1758	In Stock
200MG	Get Quote	In Stock
500MG	3515	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

C-Met inhibitor D9
Note

Research use only, not for human use.
Brief Description

C-Met inhibitor D9 is a c-Met kinase inhibitor.
Description

C-Met inhibitor D9 is a c-Met kinase inhibitor.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

c-Met/HGFR
Recptor

c-Met/HGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

299405-67-7
Formula Weight

293.32
Molecular Formula

C17H15N3O2
Purity

>98% (HPLC)
Solubility

——
SMILES

N(NC(CCC1=CC=CC=C1)=O)=C2C=3C(NC2=O)=CC=CC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Onartuzumab

Onartuzumab (MetMAb) is a humanized anti-tyrosine kinase c-MET monovalent monoclonal antibody.
Amivantamab

Amivantamab (JNJ-61186372) is a humanized antibody that recognizes epidermal growth factor receptor (EGFR) and MET proto-oncogene (MET).
Capmatinib

Capmatinib (INCB-28060, INC-280) is a highly potent, selective, ATP competitive inhibitor of c-MET kinase with IC50 of 0.13 nM.

Sign In Join Free